Similar articles for PMID: 21935500

Year	Number of Results
1997	1
1999	1
2001	1
2003	3
2004	1
2005	2
2006	2
2007	1
2008	4
2009	2
2010	5
2011	12
2012	10
2013	5
2014	9
2015	16
2016	6
2017	2
2018	5
2019	4
2020	6
2021	2
2022	2
2024	0

1

Clinical implementation of comprehensive strategies to characterize cancer genomes: opportunities and challenges.

MacConaill LE, Van Hummelen P, Meyerson M, Hahn WC. MacConaill LE, et al. Cancer Discov. 2011 Sep;1(4):297-311. doi: 10.1158/2159-8290.CD-11-0110. Cancer Discov. 2011. PMID: 21935500 Free PMC article. Review.

2

A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance.

Dietel M, Jöhrens K, Laffert MV, Hummel M, Bläker H, Pfitzner BM, Lehmann A, Denkert C, Darb-Esfahani S, Lenze D, Heppner FL, Koch A, Sers C, Klauschen F, Anagnostopoulos I. Dietel M, et al. Cancer Gene Ther. 2015 Sep;22(9):417-30. doi: 10.1038/cgt.2015.39. Epub 2015 Sep 11. Cancer Gene Ther. 2015. PMID: 26358176 Review.

3

The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones.

Workman P. Workman P. Cancer Chemother Pharmacol. 2003 Jul;52 Suppl 1:S45-56. doi: 10.1007/s00280-003-0593-0. Epub 2003 Jun 18. Cancer Chemother Pharmacol. 2003. PMID: 12819933 Review.

4

Exploring the genomes of cancer cells: progress and promise.

Stratton MR. Stratton MR. Science. 2011 Mar 25;331(6024):1553-8. doi: 10.1126/science.1204040. Science. 2011. PMID: 21436442 Review.

5

The possibility of clinical sequencing in the management of cancer.

Kou T, Kanai M, Matsumoto S, Okuno Y, Muto M. Kou T, et al. Jpn J Clin Oncol. 2016 May;46(5):399-406. doi: 10.1093/jjco/hyw018. Epub 2016 Feb 24. Jpn J Clin Oncol. 2016. PMID: 26917600 Review.

6

Prioritizing targets for precision cancer medicine.

Andre F, Mardis E, Salm M, Soria JC, Siu LL, Swanton C. Andre F, et al. Ann Oncol. 2014 Dec;25(12):2295-2303. doi: 10.1093/annonc/mdu478. Epub 2014 Oct 24. Ann Oncol. 2014. PMID: 25344359 Free article. Review.

7

Exploiting genetic complexity in cancer to improve therapeutic strategies.

Garnett MJ, McDermott U. Garnett MJ, et al. Drug Discov Today. 2012 Mar;17(5-6):188-93. doi: 10.1016/j.drudis.2012.01.025. Epub 2012 Feb 8. Drug Discov Today. 2012. PMID: 22342219 Free PMC article.

8

Impact of tumor sequencing on the use of anticancer drugs.

Thomas F, Desmedt C, Aftimos P, Awada A. Thomas F, et al. Curr Opin Oncol. 2014 May;26(3):347-56. doi: 10.1097/CCO.0000000000000078. Curr Opin Oncol. 2014. PMID: 24709974 Review.

9

Targeting FGFR Signaling in Cancer.

Touat M, Ileana E, Postel-Vinay S, André F, Soria JC. Touat M, et al. Clin Cancer Res. 2015 Jun 15;21(12):2684-94. doi: 10.1158/1078-0432.CCR-14-2329. Clin Cancer Res. 2015. PMID: 26078430 Review.

10

PanDrugs: a novel method to prioritize anticancer drug treatments according to individual genomic data.

Piñeiro-Yáñez E, Reboiro-Jato M, Gómez-López G, Perales-Patón J, Troulé K, Rodríguez JM, Tejero H, Shimamura T, López-Casas PP, Carretero J, Valencia A, Hidalgo M, Glez-Peña D, Al-Shahrour F. Piñeiro-Yáñez E, et al. Genome Med. 2018 May 31;10(1):41. doi: 10.1186/s13073-018-0546-1. Genome Med. 2018. PMID: 29848362 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

95 results

Results by year